Glenn Greenberg Holdings Activity

Brave Warrior Advisors Portfolio 13F

Brave Warrior Advisors has disclosed a total of 31 changes to the portfolio in the latest (2023 Q4) SEC report(s): increased the number of shares of 9, bought 2 totally new, decreased the number of shares of 14 and completely sold out 6 position(s).

What stocks is Glenn Greenberg buying now?

In the recent quarter Glenn Greenberg has bought 11 securities out of which top 5 purchases (by % change to portfolio) are (ANTM) ANTHEM INC (added shares +7.93%), (OMF) ONEMAIN HOLDINGS INC (added shares +21.1%), (DFS) DISCOVER FINANCIAL SERVICES (added shares +10.58%), (RYAAY) RYANAIR HOLDINGS PLC-SP ADR (new buy) and (ABG) ASBURY AUTOMOTIVE GROUP (added shares +1.13%).

What does Glenn Greenberg invest in?

Glenn Greenberg's top 5 holdings (by % of portfolio) are (ANTM) ANTHEM INC (19.76%), (FNF) FIDELITY NATIONAL FINANCIAL (11.5%), (PRI) PRIMERICA INC (10.38%), (APO) APOLLO GLOBAL MANAGEMENT INC (10.01%) and (OMF) ONEMAIN HOLDINGS INC (7.53%).

In the latest report(s) the following changes have been made to the top investments: (ANTM) ANTHEM INC (added shares +7.93%), (FNF) FIDELITY NATIONAL FINANCIAL (reduced shares -0.48%), (PRI) PRIMERICA INC (reduced shares -0.11%), (APO) APOLLO GLOBAL MANAGEMENT INC (reduced shares -33.68%) and (OMF) ONEMAIN HOLDINGS INC (added shares +21.1%).

2014 Q4 (13 results)
VRX
-6.98%
-459,973
-2.29%
$143.11
-
30.53%
VPRT
-100.00%
-4,580,125
-8.74%
$54.79
-
0.00%
SCHW
+1.57%
+130,658
+0.14%
$30.19
148.39% $74.99
8.91%
PRI
-29.61%
-986,330
-1.86%
$54.26
293.40% $213.46
4.43%
MSFT
+5.92%
+251,871
+0.46%
$46.45
774.75% $406.32
8.28%
KMR
-100.00%
-2,398,793
-7.86%
$94.15
-
0.00%
KMI
buy
+4,193,877
+6.18%
$42.31
55.85% $18.68
6.18%
JPM
+14.31%
+520,980
+1.14%
$62.58
209.19% $193.49
9.07%
HAL
buy
+3,706,410
+5.67%
$39.33
2.01% $38.54
5.67%
ESRX
-17.94%
-894,074
-2.64%
$84.67
-
12.05%
EQIX
+17.28%
+129,490
+0.99%
$219.91
232.68% $731.61
0.00%
BHI
buy
+333,983
+0.70%
$56.07
-
0.70%
9912349D
buy
+2,833,719
+7.38%
$74.84
-
7.38%
2014 Q3 (11 results)
VRX
+8.86%
+536,140
+2.61%
$131.20
-
32.02%
VPRT
+26.15%
+949,435
+1.93%
$54.79
-
0.00%
SCHW
-0.04%
-3,228
-0.00%
$29.39
155.15% $74.99
9.09%
PRI
-0.79%
-26,654
-0.05%
$48.22
342.68% $213.46
5.95%
ORCL
-100.00%
-4,062,659
-11.85%
$40.53
189.19% $117.21
0.00%
MSFT
-0.10%
-4,724
-0.01%
$46.36
776.45% $406.32
8.30%
KMR
-15.45%
-438,254
-1.53%
$94.15
-
0.00%
JPM
buy
+3,641,450
+8.13%
$60.24
221.20% $193.49
8.13%
HAL
-100.00%
-37,511
-0.19%
$71.01
45.73% $38.54
0.00%
ESRX
+6.50%
+294,911
+0.80%
$70.63
-
13.04%
EQIX
+42.72%
+224,322
+1.71%
$206.09
254.99% $731.61
5.72%
2014 Q2 (10 results)
VRX
+8.19%
+457,884
+2.33%
$126.12
-
30.78%
VPRT
+14.26%
+453,030
+0.74%
$40.46
-
5.92%
SCHW
+15.79%
+1,138,348
+1.24%
$26.93
178.46% $74.99
9.07%
PRI
-0.54%
-18,307
-0.04%
$47.85
346.10% $213.46
6.48%
ORCL
+1.12%
+45,048
+0.14%
$40.53
189.19% $117.21
0.00%
MSFT
+21.45%
+854,783
+1.44%
$41.70
874.39% $406.32
8.14%
KMR
-12.98%
-423,076
-1.35%
$78.93
-
9.03%
HAL
-98.26%
-2,121,968
-11.47%
$71.01
45.73% $38.54
0.00%
ESRX
+31.94%
+1,132,688
+3.17%
$69.33
-
13.08%
EQIX
buy
+525,047
+4.32%
$203.77
259.03% $731.61
4.32%
2014 Q1 (11 results)
VRX
-8.52%
-291,574
-2.77%
$131.83
-
29.80%
VPRT
-0.37%
-11,645
-0.02%
$49.22
-
6.32%
SCHW
-9.37%
-745,336
-0.82%
$27.33
174.39% $74.99
7.96%
PRI
-0.40%
-7,779
-0.03%
$47.11
353.11% $213.46
6.43%
ORCL
+10.33%
+730,575
+1.21%
$40.91
186.51% $117.21
12.90%
MSFT
+0.59%
+23,218
+0.04%
$40.99
891.26% $406.32
6.60%
KMR
+78.88%
+848,215
+4.16%
$71.67
-
9.44%
HAL
-14.18%
-673,022
-1.60%
$58.89
34.56% $38.54
9.70%
ESRX
-10.42%
-412,381
-1.25%
$75.09
-
10.76%
CMCSK
-100.00%
-1,830,521
-3.69%
$49.88
-
0.00%
1580477D
-100.00%
-2,294,480
-0.91%
$9.76
-
0.00%
45 of 734

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.